Picture of Soligenix logo

SNGX — Soligenix News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: Soligenix Receives Usan Approval For "Hypericin Sodium" As Nonproprietary Name For Novel Active Ingredient In Hybryte And Sgx302

April 5 (Reuters) - Soligenix Inc  SNGX.O :
    * SOLIGENIX RECEIVES USAN APPROVAL FOR "HYPERICIN SODIUM" AS
NONPROPRIETARY NAME FOR NOVEL ACTIVE INGREDIENT IN HYBRYTE™ AND
SGX302

Source text for Eikon:  ID:nPn21HrxHa 
Further company coverage:  SNGX.O 

 ((reuters.briefs@thomsonreuters.com;))

Recent news on Soligenix

See all news